Patent Assignment
Reel/Frame 061236/0538
Assignment of Assignor's Interest
Recorded: 2022-08-19
Pages: 7
Assignors
NICHOLS, DAVID E.
Executed: 2021-02-27
JOHNSON, GRAHAM
Executed: 2021-02-25
ZAVAREH, HOOSHANG S.
Executed: 2021-02-25
Assignee
ELEUSIS THERAPEUTICS US, INC.
99 WALL STREET #2205, NEW YORK, NEW YORK, 10005
Covered Property
(1)
Pharmaceutically Acceptable Salts of Psilocin and Uses Thereof
Patent:
11,680,043 →
Application:
17/708,264 →
Publication:
US 2022/0289676
PCT:
PCT/US2022/015897 ↗
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Agreement
Aug 9, 2022
From: ELEUSIS THERAPUTICS US, INC.
To: BECKLEY PSYTECH LIMITED
Reel/Frame 061119/0222 →
Assignment of Assignor's Interest
Aug 19, 2022
From: WOMBWELL, CLAIRE; RIXSON, DANIEL; HADDOW, PETER; SHEARD, CARRIE
To: JOHNSON MATTHEY PLC
Reel/Frame 061237/0108 →
Assignment of Assignor's Interest
Aug 19, 2022
From: JOHNSON MATTHEY PLC
To: ELEUSIS THERAPEUTICS US, INC.
Reel/Frame 061237/0518 →
Assignment of Assignor's Interest
Aug 19, 2022
From: SCHWARZ, ALEXANDER
To: ELEUSIS THERAPEUTICS US, INC.
Reel/Frame 061241/0529 →